Bio/Data Corporation supports the physicians, scientists, medical technologists and technicians in laboratories around the world who work to develop groundbreaking products that lead to a better understanding of hemostasis, thrombosis, and platelet function. We are proud to support their work discovering better treatments that improve the quality of patients’ lives.
We are singularly focused on creating instruments, technologies and reagents that provide medical professionals with reliable test results for assessing various stages of hemostasis and platelet function disorders, including von Willebrand Disease and Glanzmann’s Disease, and to monitor the use of anti-platelet drugs like Plavix® and aspirin.
Founded in 1969, Bio/Data Corporation pioneered the use of optical and kinetic clot detection for Coagulation Analyzers and introduced the first automated platelet aggregometer in 1974. We continued to lead the industry by introducing the first dual channel platelet aggregometer and marketing a complete line of aggregation reagents. We also launched the first von Willebrand (vW) Factor Assay® kit.